Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koma Biotech is a South Korea-based life science tools and services company that supplies research-use reagents, instruments, and analytical services for biomedical research and drug discovery. Its offerings span proteins, antibodies, viruses, cell line production services, multiplex assay solutions, flow cytometry-related products, cell analysis assay kits, and bioreactor-related products for cell therapy manufacturing support. The company also provides custom production services and drug-discovery-oriented analysis services, including work associated with Eurofins Discovery offerings. Publicly available descriptions indicate that Koma Biotech was founded in the 1990s and remains an operating private company in Seoul. It appears to function primarily as a commercial supplier and service partner rather than a therapeutics developer with a disclosed clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koma Biotech.